BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 327642)

  • 1. Significance of the cellular component of the maternal immunologic endowment in milk.
    Head JR; Beer AE; Billingham RE
    Transplant Proc; 1977 Jun; 9(2):1465-71. PubMed ID: 327642
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure to induce chimerism or tolerance in mice with monoclonal anti-T cell antibodies plus allogeneic bone marrow infusion.
    Auchincloss H; Ghobrial RR; Shea S; Pierson RN; Winn HJ
    Transplant Proc; 1988 Dec; 20(6):1190-3. PubMed ID: 3059601
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
    Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
    J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    J Surg Res; 2002 May; 104(1):29-35. PubMed ID: 11971674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
    J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
    Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
    J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal analysis of T cell unresponsiveness to alloantigens induced by neonatal injection of F1 spleen cells into parental mice.
    Feng HM; Glasebrook AL; Engers HD; Louis JA
    J Immunol; 1983 Nov; 131(5):2165-9. PubMed ID: 6195253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective production of IFN-gamma in neonatally tolerant mice: involvement of IL-10.
    Donckier V; Abramowicz D; Durez P; Gérard C; Velu T; Goldman M
    Transplant Proc; 1994 Feb; 26(1):237. PubMed ID: 8108955
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 11. Kupffer cell blockade inhibits induction of tolerance by the portal venous route.
    Callery MP; Kamei T; Flye MW
    Transplantation; 1989 Jun; 47(6):1092-4. PubMed ID: 2734830
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.
    Fan J; Ahmed A; Bonavida B
    J Immunol; 1980 Dec; 125(6):2444-53. PubMed ID: 6159409
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
    Klassen LW; Zarate A; Gelfand MC; Steinberg AD
    J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic thymus transplantation as a means to induce transplantation tolerance.
    Waer M; Vandeputte M
    Transplant Proc; 1990 Aug; 22(4):1970. PubMed ID: 2389500
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses.
    Shaw J; Caplan B; Paetkau V; Pilarski LM; Delovitch TL; McKenzie IF
    J Immunol; 1980 May; 124(5):2231-9. PubMed ID: 6965968
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of cell-mediated immunity in tumor eradication by hyperthermia.
    Alfieri AA; Hahn EW; Kim JH
    Cancer Res; 1981 Apr; 41(4):1301-5. PubMed ID: 6971146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-induced unresponsiveness results in altered T cell signaling.
    McKay DB; Irie HY; Hollander G; Ferrara JL; Strom TB; Li Y; Burakoff SJ
    J Immunol; 1999 Dec; 163(12):6455-61. PubMed ID: 10586036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of self-reactive T cells in nude mice grafted with neonatal allogeneic thymus.
    Yuuki H; Yoshikai Y; Kishihara K; Iwasaki A; Matsuzaki G; Ogimoto M; Nomoto K
    J Immunol; 1990 Jan; 144(2):474-9. PubMed ID: 2136892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.